Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

MK-2870 i kombinasjon med Pembrolizumab versus Pembrolizumab alene ved metastatisk ikke-småcellet lungekreft (NSCLC) med programmert celledødsligand 1 (PD-L1) Tumorproporsjonsscore (TPS) ≥ 50 % (MK-2870-007) (TroFuse-007)

30. oktober 2026 oppdatert av: Merck Sharp & Dohme LLC

En randomisert, åpen fase 3-studie av MK-2870 i kombinasjon med Pembrolizumab sammenlignet med Pembrolizumab monoterapi i førstelinjebehandling av deltakere med metastatisk ikke-småcellet lungekreft med PD-L1 TPS større enn eller lik 50 %

The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival (OS). The primary hypothesis is that the combination of sacituzumab tirumotecan and pembrolizumab is superior to pembrolizumab alone with respect to OS.

Studieoversikt

Studietype

Intervensjonell

Registrering (Antatt)

614

Fase

  • Fase 3

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

      • Buenos Aires, Argentina, C1118AAT
        • Rekruttering
        • Hospital Aleman-Oncology ( Site 0300)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +541148277000
    • Buenos Aires
      • Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, C1426ANZ
        • Rekruttering
        • Instituto Alexander Fleming ( Site 0306)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +54 9 011-3221-8900
    • Buenos Aires F.D.
      • Buenos Aires, Buenos Aires F.D., Argentina, C1280AEB
        • Rekruttering
        • Hospital Británico de Buenos Aires-Oncology ( Site 0304)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +541143096807
    • Córdoba Province
      • Río Cuarto, Córdoba Province, Argentina, X5800ALB
        • Rekruttering
        • Centro Privado de RMI Río Cuarto S.A. II ( Site 0310)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +54351153819050
    • Santa Fe Province
      • Rosario, Santa Fe Province, Argentina, S2000KZE
        • Rekruttering
        • Instituto de Oncología de Rosario ( Site 0301)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +549-341-5778394
    • New South Wales
      • Port Macquarie, New South Wales, Australia, 2444
        • Rekruttering
        • Port Macquarie - Mid North Coast Cancer Institute-Medical Oncology ( Site 3002)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +61265801820
      • Westmead, New South Wales, Australia, 2145
        • Rekruttering
        • Westmead Hospital ( Site 3000)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +61247343500
    • Victoria
      • Ballarat Central, Victoria, Australia, 3350
        • Fullført
        • Grampians Health-Medical Oncology ( Site 3001)
      • Epping, Victoria, Australia, 3076
        • Rekruttering
        • Northern Hospital ( Site 3003)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +61384058715
      • Frankston, Victoria, Australia, 3199
        • Rekruttering
        • Peninsula University Hospital ( Site 3004)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +61397847175
      • Rio de Janeiro, Brasil, 20230-130
        • Rekruttering
        • Instituto Nacional de Câncer - INCA ( Site 0405)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +552132076564
      • São Paulo, Brasil, 04014-012
        • Rekruttering
        • Núcleo de Pesquisa Clínica da Rede São Camilo ( Site 0401)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +551144500300
    • Rio Grande do Sul
      • Porto Alegre, Rio Grande do Sul, Brasil, 90020-090
        • Rekruttering
        • Irmandade da Santa Casa de Misericórdia de Porto Alegre ( Site 0409)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +55 51 3214 8151
      • Santa Maria, Rio Grande do Sul, Brasil, 97015-450
        • Aktiv, ikke rekrutterende
        • Clinica Viver ( Site 0400)
    • São Paulo
      • Barretos, São Paulo, Brasil, 14784400
        • Rekruttering
        • Fundação Pio XII - Hospital de Câncer de Barretos ( Site 0402)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +551733216637
      • São José do Rio Preto, São Paulo, Brasil, 15090000
        • Rekruttering
        • Fundação Faculdade Regional de Medicina de São José do Rio Preto ( Site 0406)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +551732015054
    • Ontario
      • Brampton, Ontario, Canada, L6R 3J7
        • Rekruttering
        • William Osler Health System ( Site 0203)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 905-494-2120
      • Mississauga, Ontario, Canada, L5M 2N1
        • Rekruttering
        • Trillium Health Partners - Credit Valley Hospital ( Site 0202)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 905-813-1100x4299
    • Quebec
      • Montreal, Quebec, Canada, H4A 3J1
        • Fullført
        • McGill University Health Centre ( Site 0200)
      • Antofagasta, Chile, 1263521
        • Rekruttering
        • Bradford Hill Norte ( Site 0516)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 56442023631
    • Maule Region
      • Talca, Maule Region, Chile, 3465584
        • Rekruttering
        • Clinica Universidad Catolica del Maule-Oncology ( Site 0501)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 56947532700
    • Region M. de Santiago
      • Santiago, Region M. de Santiago, Chile, 7500713
        • Rekruttering
        • Orlandi Oncologia-Oncology ( Site 0504)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 56226057491
      • Santiago, Region M. de Santiago, Chile, 7500921
        • Rekruttering
        • FALP-UIDO ( Site 0509)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 56224205098
      • Santiago, Region M. de Santiago, Chile, 8420383
        • Rekruttering
        • Bradfordhill-Clinical Area ( Site 0507)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 56229490970
    • Bogota D.C.
      • Bogotá, Bogota D.C., Colombia, 110131
        • Rekruttering
        • FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO ( Site 0600)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 3219198898
    • Departamento de Córdoba
      • Montería, Departamento de Córdoba, Colombia, 230002
        • Rekruttering
        • IMAT S.A.S ( Site 0602)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +57 (3135342052)
    • Risaralda Department
      • Pereira, Risaralda Department, Colombia, 660001
        • Rekruttering
        • Oncologos del Occidente ( Site 0603)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 573002558656
    • Central Jutland
      • Herning, Central Jutland, Danmark, 7400
        • Rekruttering
        • Regionshospitalet Gødstrup-Kræftklinikken ( Site 1204)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +45 78430453
    • North Denmark
      • Aalborg, North Denmark, Danmark, 9000
        • Rekruttering
        • Aalborg Universitetshospital, Syd-Department of Oncology ( Site 1201)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +45 97660000
    • Region Syddanmark
      • Odense C, Region Syddanmark, Danmark, 5000
        • Rekruttering
        • Odense Universitetshospital ( Site 1200)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +4523612809
    • Arizona
      • Phoenix, Arizona, Forente stater, 85054
        • Rekruttering
        • Mayo Clinic in Arizona - Phoenix ( Site 0147)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 480-342-4800
    • California
      • Burbank, California, Forente stater, 91505
        • Rekruttering
        • Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center ( Site 0130)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 818-840-0921
    • Colorado
      • Grand Junction, Colorado, Forente stater, 81501
        • Rekruttering
        • Cancer Centers of Colorado St. Mary's Regional Hospital ( Site 0132)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 970-298-7638
    • Florida
      • Jacksonville, Florida, Forente stater, 32224
        • Rekruttering
        • Mayo Clinic in Florida-Mayo Clinic Comprehensive Cancer Center ( Site 0133)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 904-953-9945
    • Georgia
      • Marietta, Georgia, Forente stater, 30060
        • Fullført
        • Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital-Research ( Site 0106)
    • Kentucky
      • Louisville, Kentucky, Forente stater, 40202
        • Fullført
        • The University of Louisville, James Graham Brown Cancer Center ( Site 0121)
    • Maine
      • Westbrook, Maine, Forente stater, 04092
        • Rekruttering
        • New England Cancer Specialists ( Site 0143)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 207-303-3424
    • Massachusetts
      • Worcester, Massachusetts, Forente stater, 01655
        • Fullført
        • University of Massachusetts Chan Medical School-Division of Hematology/Oncology ( Site 0144)
    • Minnesota
      • Minneapolis, Minnesota, Forente stater, 55407
        • Rekruttering
        • Allina Health Cancer Institute - Abbott Northwestern Hospital ( Site 0115)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 651-241-7025
      • Rochester, Minnesota, Forente stater, 55905
        • Rekruttering
        • Mayo Clinic - Rochester ( Site 0148)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 507-538-1665
    • Mississippi
      • Hattiesburg, Mississippi, Forente stater, 39401
        • Rekruttering
        • Hattiesburg Clinic Hematology/Oncology ( Site 0104)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 601-261-1700
    • Nevada
      • Reno, Nevada, Forente stater, 89502
        • Rekruttering
        • Renown Regional Medical Center-Renown Health Medical Oncology ( Site 0134)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 775-982-5050
    • Ohio
      • Cleveland, Ohio, Forente stater, 44106
        • Fullført
        • University Hospitals Cleveland Medical Center ( Site 0119)
    • Oregon
      • Corvallis, Oregon, Forente stater, 97330
        • Rekruttering
        • Good Samaritan Regional Medical Center-Samaritan Pastega Regional Cancer Center ( Site 0117)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 541-768-4950
    • Texas
      • Houston, Texas, Forente stater, 77030
        • Fullført
        • Oncology Consultants P.A. ( Site 0129)
    • Bouches-du-Rhone
      • Marseille, Bouches-du-Rhone, Frankrike, 13008
        • Rekruttering
        • Hôpital Saint Joseph-ONCOLOGY ( Site 1308)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +33491806500
    • Herault
      • Montpellier, Herault, Frankrike, 34298
        • Rekruttering
        • Institut Régional du Cancer Montpellier-Medical Oncology ( Site 1309)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +33467613100
    • Limousin
      • Limoges, Limousin, Frankrike, 87042
        • Rekruttering
        • Centre Hospitalier Universitaire de Limoges - Hôpital Dupuyt-Unité d'oncologie thoracique et cutané ( Site 1303)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +33555056892
    • Meurthe-et-Moselle
      • Nancy, Meurthe-et-Moselle, Frankrike, 54000
        • Rekruttering
        • Centre d'Oncologie de Gentilly ( Site 1301)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 0033355685518
    • Pyrenees-Atlantiques
      • Bayonne, Pyrenees-Atlantiques, Frankrike, 64109
        • Rekruttering
        • Centre Hospitalier de la Cote Basque ( Site 1300)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 33559443172
    • Rhone
      • Villefranche-sur-Saône, Rhone, Frankrike, 69655
        • Rekruttering
        • L HOPITAL NORD OUEST ( Site 1310)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +33642346915
    • Somme
      • Amiens, Somme, Frankrike, 80000
        • Rekruttering
        • Clinique de l'Europe-Service de pneumologie ( Site 1304)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 00 33 3 23 06 72 24
    • Vienne
      • Poitiers, Vienne, Frankrike, 86021
        • Rekruttering
        • Centre Hospitalier Universitaire de Poitiers-Pôle régional de cancérologie ( Site 1305)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 00330516604212
      • Bergamo, Italia, 24127
        • Rekruttering
        • Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII ( Site 1810)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +390352673687
      • Catanzaro, Italia, 88100
        • Rekruttering
        • AOU Renato Dulbecco ( Site 1801)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +390961883221
      • Florence, Italia, 50134
        • Rekruttering
        • Azienda Ospedaliera Universitaria Careggi ( Site 1809)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +390557947298
      • Roma, Italia, 00168
        • Rekruttering
        • Fondazione Policlinico Universitario Agostino Gemelli IRCCS -Medical Oncology ( Site 1806)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +390630154844
    • Apulia
      • Bari, Apulia, Italia, 70124
        • Rekruttering
        • Instituto Tumori Giovanni Paolo II-SSD Oncologia Medica per la Patologia Toracica ( Site 1804)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +390805555442
    • Emilia-Romagna
      • Meldola, Emilia-Romagna, Italia, 47014
        • Rekruttering
        • IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori"-Oncologia Medica ( Site 1807)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +390543739100
    • Friuli Venezia Giulia
      • Udine, Friuli Venezia Giulia, Italia, 33100
        • Rekruttering
        • P.O. "S. Maria della Misericordia" Azienda Sanitaria Univers-Oncology Department ( Site 1803)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +390432552751
    • Lombardy
      • Milan, Lombardy, Italia, 20133
        • Rekruttering
        • Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 1800)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +390223903813
      • Fukuoka, Japan, 810-8563
        • Aktiv, ikke rekrutterende
        • National Hospital Organization Kyushu Medical Center ( Site 3416)
      • Kumamoto, Japan, 861-4193
        • Rekruttering
        • Saiseikai Kumamoto Hospital ( Site 3419)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-96-351-8000
      • Osaka, Japan, 541-8567
        • Rekruttering
        • Osaka Prefectural Hospital Organization Osaka International Cancer Institute ( Site 3414)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-6-6945-1181
    • Aichi-ken
      • Toyoake, Aichi-ken, Japan, 470-1192
        • Rekruttering
        • Fujita Health University Hospital ( Site 3411)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-562-93-2111
    • Aomori
      • Hirosaki, Aomori, Japan, 036-8563
        • Aktiv, ikke rekrutterende
        • Hirosaki University Hospital ( Site 3429)
    • Chiba
      • Kashiwa, Chiba, Japan, 277-8577
        • Rekruttering
        • National Cancer Center Hospital East ( Site 3403)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-4-7133-1111
    • Ehime
      • Matsuyama, Ehime, Japan, 791-0280
        • Rekruttering
        • National Hospital Organization Shikoku Cancer Center ( Site 3415)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-89-999-1111
    • Fukuoka
      • Fukuoka, Fukuoka, Japan, 811-1395
        • Rekruttering
        • National Hospital Organization Kyushu Cancer Center ( Site 3417)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-92-541-3231
      • Kurume, Fukuoka, Japan, 830-0011
        • Rekruttering
        • Kurume University Hospital ( Site 3418)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-942-35-3311
    • Gunma
      • Ōta, Gunma, Japan, 373-8550
        • Rekruttering
        • Gunma Prefectural Cancer Center ( Site 3402)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-276-38-0771
    • Hyōgo
      • Himeji, Hyōgo, Japan, 670-8520
        • Rekruttering
        • National Hospital Organization Himeji Medical Center ( Site 3426)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-79-225-3211
    • Iwate
      • Shiwa-gun, Iwate, Japan, 028-3695
        • Rekruttering
        • Iwate Medical University Hospital ( Site 3428)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-19-613-7111
    • Kanagawa
      • Kawasaki, Kanagawa, Japan, 216-8511
        • Rekruttering
        • St. Marianna University Hospital ( Site 3421)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-44-977-8111
      • Yokohama, Kanagawa, Japan, 241-8515
        • Rekruttering
        • Kanagawa Cancer Center ( Site 3408)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-45-520-2222
      • Yokohama, Kanagawa, Japan, 221-0855
        • Rekruttering
        • Yokohama Municipal Citizen's Hospital ( Site 3425)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-45-316-4580
    • Mie-ken
      • Matsusaka, Mie-ken, Japan, 515-8544
        • Aktiv, ikke rekrutterende
        • Saiseikai Matsusaka Municipal Hospital ( Site 3422)
    • Miyagi
      • Sendai, Miyagi, Japan, 981-0914
        • Rekruttering
        • Sendai Kousei Hospital ( Site 3400)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-22-728-8000
      • Sendai, Miyagi, Japan, 980-8574
        • Rekruttering
        • Tohoku University Hospital ( Site 3424)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-22-717-7000
    • Osaka
      • Hirakata, Osaka, Japan, 573-1191
        • Rekruttering
        • Kansai Medical University Hospital ( Site 3412)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-72-804-0101
      • Takatsuki, Osaka, Japan, 569-8686
        • Rekruttering
        • Osaka Medical and Pharmaceutical University Hospital ( Site 3413)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-72-683-1221
    • Saga-ken
      • Ureshino, Saga-ken, Japan, 843-0393
        • Rekruttering
        • National Hospital Organization Ureshino Medical Center ( Site 3427)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-954-43-1120
    • Saitama
      • Niigata, Saitama, Japan, 951-8566
        • Rekruttering
        • Niigata Cancer Center Hospital ( Site 3409)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-25-266-5111
    • Shizuoka
      • Suntogun, Shizuoka, Japan, 411-8777
        • Rekruttering
        • Shizuoka Cancer Center ( Site 3410)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-55-989-5222
    • Tochigi
      • Shimotsugagun, Tochigi, Japan, 321-0293
        • Rekruttering
        • Dokkyo Medical University Hospital ( Site 3401)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-282-86-1111
    • Tokyo
      • Bunkyo, Tokyo, Japan, 113-8677
        • Rekruttering
        • Tokyo Metropolitan Komagome Hospital ( Site 3405)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-3-3823-2101
      • Koto, Tokyo, Japan, 135-8550
        • Rekruttering
        • Cancer Institute Hospital of JFCR ( Site 3404)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-3-3520-0111
      • Shinjuku, Tokyo, Japan, 160-0023
        • Rekruttering
        • Tokyo Medical University Hospital ( Site 3407)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-3-3342-6111
      • Shinjuku, Tokyo, Japan, 162-8655
        • Rekruttering
        • National Center for Global Health and Medicine ( Site 3406)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-3-3202-7181
      • Ōta-ku, Tokyo, Japan, 143-8541
        • Rekruttering
        • Toho University Omori Medical Center ( Site 3420)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-3-3762-4151
    • Yamaguchi
      • Ube, Yamaguchi, Japan, 755-0241
        • Rekruttering
        • National Hospital Organization Yamaguchi Ube Medical Center ( Site 3423)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +81-836-58-2300
    • Anhui
      • Hefei, Anhui, Kina, 230000
        • Fullført
        • Second Affiliated hospital of Anhui Medical University ( Site 3133)
    • Beijing Municipality
      • Beijing, Beijing Municipality, Kina, 100142
        • Aktiv, ikke rekrutterende
        • Beijing Cancer hospital-intrathoratic deparmtment II ( Site 3101)
      • Beijing, Beijing Municipality, Kina, 100730
        • Aktiv, ikke rekrutterende
        • Beijing Peking Union Medical College Hospital-pneumology department ( Site 3100)
    • Fujian
      • Fuzhou, Fujian, Kina, 350014
        • Aktiv, ikke rekrutterende
        • Fujian Provincial Cancer Hospital ( Site 3131)
      • Xiamen, Fujian, Kina, 361003
        • Aktiv, ikke rekrutterende
        • The First Affiliated hospital of Xiamen University-Breast Surgery ( Site 3107)
    • Guangdong
      • Guangzhou, Guangdong, Kina, 510140
        • Aktiv, ikke rekrutterende
        • The First Affiliated Hospital of Guangzhou Medical University ( Site 3134)
      • Guangzhou, Guangdong, Kina, 510515
        • Aktiv, ikke rekrutterende
        • Southern Medical University Nanfang Hospital-Depatrment of Respiratory and Critical Care Medicine ( Site 3108)
      • Zhanjiang, Guangdong, Kina, 524004
        • Fullført
        • Affiliated Hospital of Guangdong Medical University ( Site 3123)
    • Hebei
      • Shijiazhuang, Hebei, Kina, 050000
        • Aktiv, ikke rekrutterende
        • The Second Hospital of Hebei Medical University ( Site 3135)
    • Heilongjiang
      • Harbin, Heilongjiang, Kina, 150000
        • Aktiv, ikke rekrutterende
        • Harbin Medical University Cancer Hospital-oncology of department ( Site 3132)
    • Henan
      • Zhengzhou, Henan, Kina, 450008
        • Aktiv, ikke rekrutterende
        • Henan Cancer Hospital ( Site 3116)
    • Hubei
      • Wuhan, Hubei, Kina, 430000
        • Aktiv, ikke rekrutterende
        • Tongji Hospital Tongji Medical,Science & Technology ( Site 3117)
      • Wuhan, Hubei, Kina, 430079
        • Aktiv, ikke rekrutterende
        • Hubei Cancer Hospital ( Site 3106)
      • Wuhan, Hubei, Kina, 430048
        • Aktiv, ikke rekrutterende
        • Wuhan Union Hospital ( Site 3130)
      • Xiangyang, Hubei, Kina, 441106
        • Aktiv, ikke rekrutterende
        • Xiangyang Central Hospital-oncology department ( Site 3136)
    • Hunan
      • Changsha, Hunan, Kina, 410011
        • Aktiv, ikke rekrutterende
        • The Second Xiangya Hospital of Central South University ( Site 3138)
    • Jiangsu
      • Wuxi, Jiangsu, Kina, 214122
        • Aktiv, ikke rekrutterende
        • Affiliated Hospital of Jiangnan University(Wuxi Fourth People's Hospital ) ( Site 3113)
      • Xuzhou, Jiangsu, Kina, 221002
        • Fullført
        • The Affiliated Hospital of Xuzhou Medical College ( Site 3112)
    • Jiangxi
      • Nanchang, Jiangxi, Kina, 330006
        • Aktiv, ikke rekrutterende
        • The Second Affiliated Hospital of Nanchang University-Oncology Department ( Site 3121)
      • Nanchang, Jiangxi, Kina, 330029
        • Aktiv, ikke rekrutterende
        • Jiangxi Provincial Cancer Hospital ( Site 3143)
      • Nanchang, Jiangxi, Kina, 330006
        • Aktiv, ikke rekrutterende
        • The First Affiliated Hospital of Nanchang University-Respiratory Medicine Department ( Site 3127)
    • Jilin
      • Changchun, Jilin, Kina, 130000
        • Aktiv, ikke rekrutterende
        • Jilin Province Tumor Hospital-oncology department ( Site 3126)
    • Shandong
      • Jinan, Shandong, Kina, 250117
        • Aktiv, ikke rekrutterende
        • Shandong Cancer Hospital ( Site 3119)
      • Jinan, Shandong, Kina, 250013
        • Aktiv, ikke rekrutterende
        • Jinan Central Hospital-oncology department ( Site 3122)
    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, Kina, 200082
        • Aktiv, ikke rekrutterende
        • Shanghai Changhai Hospital ( Site 3125)
    • Sichuan
      • Chengdu, Sichuan, Kina, 610042
        • Fullført
        • Sichuan Cancer hospital. ( Site 3105)
      • Chengdu, Sichuan, Kina, 610041
        • Aktiv, ikke rekrutterende
        • West China Hospital, Sichuan University ( Site 3124)
      • Neijiang, Sichuan, Kina, 641099
        • Aktiv, ikke rekrutterende
        • The Second People's Hospital of Neijiang ( Site 3140)
    • Yunnan
      • Kunming, Yunnan, Kina, 650107
        • Aktiv, ikke rekrutterende
        • Yunnan Province Cancer Hospital ( Site 3139)
    • Zhejiang
      • Hangzhou, Zhejiang, Kina, 310003
        • Aktiv, ikke rekrutterende
        • The first Affiliated Hospital, Zhejiang University School of Medicine ( Site 3115)
      • Hangzhou, Zhejiang, Kina, 310016
        • Aktiv, ikke rekrutterende
        • Sir Run Run Shaw Hospital of Zhejiang University School of Medicine ( Site 3111)
      • Taizhou, Zhejiang, Kina, 317000
        • Aktiv, ikke rekrutterende
        • Taizhou Hospital of Zhejiang Province-Respiratory ( Site 3114)
      • Oaxaca City, Mexico, 68000
        • Rekruttering
        • Oaxaca Site Management Organization S.C. ( Site 0718)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +529511301554
      • Puebla City, Mexico, 72530
        • Rekruttering
        • Clinica Integral Internacional de Oncología ( Site 0714)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +522223555576
    • Jalisco
      • Guadalajara, Jalisco, Mexico, 44630
        • Rekruttering
        • CIO - Centro de Inmuno-Oncología de Occidente ( Site 0715)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 3330447001
    • Mexico City
      • Mexico City, Mexico City, Mexico, 11819
        • Rekruttering
        • Higiea Oncologia ( Site 0721)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 5552731712
    • Nuevo León
      • Monterrey, Nuevo León, Mexico, 64060
        • Fullført
        • Axis Heilsa S. de R.L. de C.V. ( Site 0719)
    • San Luis Potosí
      • San Luis Potosí City, San Luis Potosí, Mexico, 78200
        • Rekruttering
        • Centro de Atención e Investigación Cardiovascular del Potosí ( Site 0713)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +52 444 585 2263
    • North Brabant
      • Breda, North Brabant, Nederland, 4818 CK
        • Rekruttering
        • Amphia Ziekenhuis, locatie Breda Molengracht-long oncologie ( Site 1901)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 0031765955349
      • Tilburg, North Brabant, Nederland, 5022 GC
        • Rekruttering
        • ETZ Elisabeth-Department of Pulmonary Diseases ( Site 1902)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 0031132213101
    • Overijssel
      • Zwolle, Overijssel, Nederland, 8025 AB
        • Rekruttering
        • Isala, locatie Zwolle-Poli Longziekten ( Site 1903)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 0031886243254
      • Lima, Peru, 15038
        • Rekruttering
        • INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS ( Site 0850)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +51940238282
      • Lima, Peru, Lima 31
        • Rekruttering
        • Hospital Cayetano Heredia-Oncology ( Site 0855)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +51 986981097
      • Lima, Peru, 15047
        • Rekruttering
        • Instituto Neuro Cardiovascular de las Americas ( Site 0856)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +51991366612
      • Lima, Peru, 15036
        • Aktiv, ikke rekrutterende
        • IPOR Instituto Peruano de Oncología & Radioterapia-Centro de Investigación ( Site 0851)
    • Ariqipa
      • Arequipa, Ariqipa, Peru, 15036
        • Aktiv, ikke rekrutterende
        • Clinica Vallesur - AUNA ( Site 0854)
    • Muni Metro de Lima
      • Surquillo, Muni Metro de Lima, Peru, 15038
        • Rekruttering
        • Detecta Clínica ( Site 0853)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +51992783190
    • Kuyavian-Pomeranian Voivodeship
      • Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Polen, 85-796
        • Rekruttering
        • Centrum Onkologii im. Prof. Franciszka Lukaszczyka ( Site 2003)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 523743589
      • Grudziądz, Kuyavian-Pomeranian Voivodeship, Polen, 86-300
        • Fullført
        • Regionalny Szpital Specjalistyczny im. dr. Władyslawa Biegańskiego ( Site 2013)
      • Torun, Kuyavian-Pomeranian Voivodeship, Polen, 87-100
        • Fullført
        • Wojewodzki Szpital Zespolony im Ludwika Rydygiera w Toruniu ( Site 2016)
    • Lesser Poland Voivodeship
      • Krakow, Lesser Poland Voivodeship, Polen, 31-826
        • Rekruttering
        • Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie-Oncology Department ( Site 2015)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 12 646 82 85
    • Masovian Voivodeship
      • Warsaw, Masovian Voivodeship, Polen, 02-781
        • Rekruttering
        • Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier ( Site 2000)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +48225462248
      • Warsaw, Masovian Voivodeship, Polen, 01-138
        • Rekruttering
        • Instytut Gruzlicy i Chorob Pluc w Warszawie ( Site 2011)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 00 48 22 431 22 79
    • Podkarpackie Voivodeship
      • Przemyśl, Podkarpackie Voivodeship, Polen, 37-700
        • Rekruttering
        • Wojewodzki Szpital im. Sw. Ojca Pio w Przemyslu ( Site 2001)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 16 677 55 10
    • Warmian-Masurian Voivodeship
      • Olsztyn, Warmian-Masurian Voivodeship, Polen, 10-357
        • Rekruttering
        • Warminsko-Mazurskie Centrum Chorob Pluc w Olsztynie ( Site 2018)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +48895322978
    • Łódź Voivodeship
      • Lodz, Łódź Voivodeship, Polen, 90-549
        • Fullført
        • SPZOZ Uniwersytecki Szpital Kliniczny Im. Wojskowej Akademii Medycznej UM W Łodzi Centralny Szpital ( Site 2012)
      • Lisbon, Portugal, 1350-352
        • Rekruttering
        • Hospital CUF - Tejo ( Site 2100)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +351213926100
    • Lisbon District
      • Lisbon, Lisbon District, Portugal, 1099-023
        • Rekruttering
        • Instituto Português de Oncologia de Lisboa Francisco Gentil ( Site 2104)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 00351217229800
      • Lisbon, Lisbon District, Portugal, 1769-001
        • Rekruttering
        • Unidade Local de Saude de Santa Maria - Hospital Pulido Valente ( Site 2101)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 00351217805000
    • Madeira
      • Funchal, Madeira, Portugal, 9004-514
        • Rekruttering
        • Hospital Dr. Nélio Mendonça ( Site 2105)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +351291705600
    • Porto District
      • Vila Nova de Gaia, Porto District, Portugal, 4434-502
        • Fullført
        • Unidade Local de Saude Gaia/Espinho - Hospital Eduardo Santos Silva ( Site 2103)
      • Barcelona, Spania, 08035
        • Rekruttering
        • Hospital Universitari Vall d'Hebron-Oncology ( Site 2330)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +34932746000
      • Madrid, Spania, 28006
        • Rekruttering
        • Hospital La Princesa ( Site 2338)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +34915202200
      • Santa Cruz de Tenerife, Spania, 38010
        • Rekruttering
        • Hospital Universitario Nuestra Senora de la Candelaria ( Site 2339)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 922602020
      • Seville, Spania, 41013
        • Rekruttering
        • HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO-Medical Oncology ( Site 2337)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +34955013068
    • Cadiz
      • Jerez de la Frontera, Cadiz, Spania, 11407
        • Rekruttering
        • Hospital Jerez de la Frontera-UGC Oncología ( Site 2333)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +3485681420
    • La Coruna
      • A Coruña, La Coruna, Spania, 15006
        • Rekruttering
        • CHUAC-Hospital Teresa Herrera-MEDICAL ONCOLOGY ( Site 2335)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 34981178000x292872
    • Madrid
      • Pozuelo de Alarcón, Madrid, Spania, 28223
        • Rekruttering
        • HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID-ONCOLOGIA MEDICA ( Site 2331)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +34914521987
    • Malaga
      • Málaga, Malaga, Spania, 29011
        • Rekruttering
        • H.R.U Malaga - Hospital General ( Site 2332)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +34 95 130 81 30
    • Valenciana, Comunitat
      • Valencia, Valenciana, Comunitat, Spania, 46009
        • Rekruttering
        • Fundación Instituto Valenciano de Oncología-Oncologico ( Site 2336)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +34961114229
    • England
      • London, England, Storbritannia, NW3 2QG
        • Aktiv, ikke rekrutterende
        • Royal Free Hospital ( Site 2601)
    • Hampshire
      • Portsmouth, Hampshire, Storbritannia, PO6 3LY
        • Rekruttering
        • Queen Alexandra Hospital-Oncology Department ( Site 2603)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 023 9228 6000 x4078
    • Kent
      • Canterbury, Kent, Storbritannia, CT1 3NG
        • Rekruttering
        • Kent and Canterbury Hospital-Oncology Research ( Site 2606)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 01227 866393
    • London, City of
      • London, London, City of, Storbritannia, SE1 9RT
        • Aktiv, ikke rekrutterende
        • Guy's & St Thomas' NHS Foundation Trust-Oncology & Haematology Clinical Trials ( Site 2605)
    • Middlesbrough
      • Central Middlesbrough, Middlesbrough, Storbritannia, TS4 3BW
        • Aktiv, ikke rekrutterende
        • James Cook University Hospital ( Site 2604)
      • Seoul, Sør -Korea, 05505
        • Rekruttering
        • Asan Medical Center-Lung Cancer Center ( Site 3805)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 02-3010-5419
      • Seoul, Sør -Korea, 06351
        • Rekruttering
        • Samsung Medical Center-Division of Hematology/Oncology ( Site 3802)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 82-2-3410-3453
    • Kang-won-do
      • Wŏnju, Kang-won-do, Sør -Korea, 26426
        • Fullført
        • Wonju Severance Christian Hospital ( Site 3808)
    • Kyonggi-do
      • Goyang-si, Kyonggi-do, Sør -Korea, 10408
        • Rekruttering
        • National Cancer Center ( Site 3801)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +82319200406
      • Suwon, Kyonggi-do, Sør -Korea, 16247
        • Rekruttering
        • The Catholic University Of Korea St. Vincent's Hospital-Medical Oncology ( Site 3800)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 82-31-249-7744
      • Suwon, Kyonggi-do, Sør -Korea, 16499
        • Fullført
        • Ajou University Hospital-Hematology-Oncology ( Site 3806)
    • North Chungcheong
      • Cheongju-si, North Chungcheong, Sør -Korea, 28644
        • Rekruttering
        • Chungbuk National University Hospital-Internal medicine ( Site 3804)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 82-43-269-6015
    • Taegu-Kwangyokshi
      • Daegu, Taegu-Kwangyokshi, Sør -Korea, 42601
        • Rekruttering
        • Keimyung University Dongsan Hospital CRC room 1 ( Site 3807)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 82532586671
      • Hsinchu, Taiwan, 300
        • Rekruttering
        • National Taiwan University Hospital - Hsinchu branch ( Site 3901)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +886-972-651-703
      • Kaohsiung City, Taiwan, 83301
        • Rekruttering
        • Chang Gung Memorial Hospital at Kaohsiung ( Site 3902)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 88677317123
      • Kaohsiung City, Taiwan, 807
        • Fullført
        • Kaohsiung Medical University Chung-Ho Memorial Hospital ( Site 3904)
      • New Taipei City, Taiwan, 23561
        • Rekruttering
        • Taipei Medical University Shuang Ho Hospital ( Site 3912)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +886970746943
      • Taichung, Taiwan, 40705
        • Fullført
        • Taichung Veterans General Hospital-Chest ( Site 3905)
      • Tainan, Taiwan, 704
        • Rekruttering
        • National Cheng Kung University Hospital-Clinical Trial Center ( Site 3903)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 88662353535
      • Tainan, Taiwan, 71004
        • Rekruttering
        • Chi Mei Medical Center ( Site 3915)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +886980195306
      • Taipei, Taiwan, 10449
        • Rekruttering
        • Mackay Memorial Hospital ( Site 3909)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +886975835146
      • Taipei, Taiwan, 10002
        • Fullført
        • National Taiwan University Hospital-Oncology ( Site 3906)
    • Tainan
      • Tainan, Tainan, Taiwan, 73657
        • Rekruttering
        • Chi Mei Hospital - Liouying Branch ( Site 3908)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +886963051211
    • Taipei
      • Taipei City, Taipei, Taiwan, 106
        • Rekruttering
        • National Taiwan University Cancer Center (NTUCC) ( Site 3907)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +886223123456x267511
    • Bangkok
      • Bangkok, Bangkok, Thailand, 10700
        • Rekruttering
        • Faculty of Medicine Siriraj Hospital ( Site 4000)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +6624194489
      • Pathumwan, Bangkok, Thailand, 10330
        • Rekruttering
        • Chulalongkorn University ( Site 4003)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +6622564533
    • Chiang Mai
      • Muang, Chiang Mai, Thailand, 50200
        • Rekruttering
        • Maharaj Nakorn Chiang Mai Hospital ( Site 4001)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +6653935480
      • Olomouc, Tsjekkia, 779 00
        • Rekruttering
        • Fakultni nemocnice Olomouc-Klinika plicnich nemoci a tuberkulozy ( Site 1102)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +420 588 443 666
    • Ostrava Mesto
      • Ostrava, Ostrava Mesto, Tsjekkia, 703 00
        • Rekruttering
        • Nemocnice AGEL Ostrava - Vitkovice a.s.-Plicni oddeleni ( Site 1103)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +420 595 633 400
    • Pardubice Region
      • Pardubice, Pardubice Region, Tsjekkia, 532 03
        • Rekruttering
        • Multiscan-Onkologicke a radiologicke centrum Multiscan Pardubice ( Site 1105)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +420466016436
    • Praha 2
      • Prague, Praha 2, Tsjekkia, 128 08
        • Rekruttering
        • Vseobecna fakultni nemocnice v Praze-Onkologicka klinika ( Site 1106)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +420224962143
      • Adana, Tyrkia (Türkiye), 01140
        • Rekruttering
        • Adana Medical Park Seyhan Hastanesi-Medikal Onkoloji ( Site 2507)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +905056166338
      • Ankara, Tyrkia (Türkiye), 06200
        • Rekruttering
        • Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastırma Hastanesi-oncology ( Site 2506)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +903123360909
      • Ankara, Tyrkia (Türkiye), 06230
        • Rekruttering
        • Hacettepe Universite Hastaneleri-oncology hospital ( Site 2501)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +903123052841
      • Ankara, Tyrkia (Türkiye), 06520
        • Rekruttering
        • Memorial Ankara Hastanesi-Medical Oncology ( Site 2505)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +90 5067521275
      • Ankara, Tyrkia (Türkiye), 06800
        • Rekruttering
        • Ankara Bilkent Şehir Hastanesi ( Site 2500)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +903125526000
      • Denizli, Tyrkia (Türkiye), 20070
        • Rekruttering
        • Pamukkale University Medical Faculty, Fahri Goksin Oncology Centre-Oncolgyy-Hematology ( Site 2510)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 0090 258 296 5142
      • Istanbul, Tyrkia (Türkiye), 34722
        • Rekruttering
        • TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 2502)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +902166065200
      • Samsun, Tyrkia (Türkiye), 55139
        • Rekruttering
        • Ondokuz Mayıs Universitesi ( Site 2509)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +90 362 312 1919
    • Istanbul
      • Stanbul, Istanbul, Tyrkia (Türkiye), 34214
        • Rekruttering
        • Medipol Mega Universite Hastanesi-oncology ( Site 2508)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +90 5325280486
    • Kayseri
      • Talas, Kayseri, Tyrkia (Türkiye), 38039
        • Rekruttering
        • Erciyes University ( Site 2511)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +90 207 666 6270
    • İzmir
      • Bornova, İzmir, Tyrkia (Türkiye), 35100
        • Rekruttering
        • Ege Universitesi Hastanesi-Chest Diseases Department ( Site 2503)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 0090 232 390 43 34
      • Berlin, Tyskland, 13353
        • Rekruttering
        • Charité Campus Virchow-Klinikum-Department of Infectious Diseases and Pulmonary Medicine ( Site 1402)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +4930450553044
    • Bavaria
      • München, Bavaria, Tyskland, 81925
        • Rekruttering
        • Klinikum Bogenhausen-Klinik für Pneumologie und Onkologische Pneumologie ( Site 1406)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 0049892704316
      • München, Bavaria, Tyskland, 80336
        • Fullført
        • Klinikum der Ludwig-Maximilians-Universitaet Muenchen-Medizinische Klinik V ( Site 1409)
      • Nuremberg, Bavaria, Tyskland, 90419
        • Fullført
        • Klinikum Nürnberg Nord-5. Med. Klinik ( Site 1407)
    • Hesse
      • Marburg, Hesse, Tyskland, 35043
        • Rekruttering
        • Universitätsklinikum Marburg-Comprehensive Cancer Center ( Site 1412)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +4964215861819
    • Lower Saxony
      • Hanover, Lower Saxony, Tyskland, 30625
        • Rekruttering
        • Medizinische Hochschule Hannover-Department of Pneumology ( Site 1411)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 49 511 532 6553
    • North Rhine-Westphalia
      • Moers, North Rhine-Westphalia, Tyskland, 47441
        • Rekruttering
        • Bethanien Krankenhaus Moers ( Site 1400)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +49 2841 200 2297
      • Münster, North Rhine-Westphalia, Tyskland, 48149
        • Rekruttering
        • Universitätsklinikum Münster - Albert Schweitzer Campus-Medizinische Klinik A ( Site 1410)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +49 251 83-52712
    • Rhineland-Palatinate
      • Mainz, Rhineland-Palatinate, Tyskland, 55131
        • Rekruttering
        • Universitätsmedizin Johannes Gutenberg Universität Mainz- Klinik für Pneumologie ( Site 1404)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +496131177031
    • Schleswig-Holstein
      • Großhansdorf, Schleswig-Holstein, Tyskland, 22927
        • Rekruttering
        • LungenClinic Grosshansdorf-Onkologie ( Site 1401)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: +49 4102 6012421
    • Thuringia
      • Gera, Thuringia, Tyskland, 07548
        • Rekruttering
        • SRH Wald-Klinikum Gera-Zentrum für klinische Studien ( Site 1403)
        • Ta kontakt med:
          • Study Coordinator
          • Telefonnummer: 00493658287758
      • Ho Chi Minh City, Vietnam, 700000
        • Aktiv, ikke rekrutterende
        • Thong Nhat Hospital ( Site 4170)
      • Ho Chi Minh City, Vietnam, 700000
        • Aktiv, ikke rekrutterende
        • Ho Chi Minh City Oncology Hospital - Tan Phu Ward ( Site 4173)
      • Hà Nội, Vietnam, 100000
        • Aktiv, ikke rekrutterende
        • K Hospital - National Cancer Hospital ( Site 4174)
    • Hanoi
      • Hanoi, Hanoi, Vietnam, 100000
        • Aktiv, ikke rekrutterende
        • National Lung Hospital-Oncology Department ( Site 4175)
      • Hanoi, Hanoi, Vietnam, 100000
        • Aktiv, ikke rekrutterende
        • Tam Anh General Hospital ( Site 4179)
      • Ho Chi Minh, Hanoi, Vietnam, 700000
        • Aktiv, ikke rekrutterende
        • Cho Ray Hospital ( Site 4171)

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Histologically or cytologically confirmed diagnosis of squamous or nonsquamous NSCLC

    • Confirmation that epidermal growth factor receptor- (EGFR-), anaplastic lymphoma kinase- (ALK-), or proto-oncogene tyrosine-protein kinase ROS (ROS1-) directed therapy is not indicated as primary therapy
    • Provided tumor tissue that demonstrates programmed cell death ligand 1 (PD-L1) expression in ≥50% of tumor cells as assessed by an immunohistochemistry (IHC) central laboratory
    • An Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 assessed within 7 days before randomization.
    • A life expectancy of at least 3 months.
    • Human immunodeficiency virus (HIV)-infected participants must have well controlled HIV on antiretroviral therapy (ART)

Exclusion Criteria:

  • Diagnosis of small cell lung cancer or, for mixed tumors, presence of small cell elements.
  • Has Grade ≥2 peripheral neuropathy.
  • History of documented severe dry eye syndrome, severe Meibomian gland disease and/or blepharitis, or severe corneal disease that prevents/delays corneal healing.
  • Has active inflammatory bowel disease requiring immunosuppressive medication or previous clear history of inflammatory bowel disease (eg, Crohn's disease, ulcerative colitis, or chronic diarrhea).
  • Has uncontrolled, significant cardiovascular disease or cerebrovascular disease within the 6 months preceding study intervention.
  • Received prior systemic anticancer therapy for their metastatic NSCLC.
  • Received prior therapy with an anti-PD-1, anti-PD-L1, or anti-PD-L2 agent, or with an agent directed to another stimulatory or coinhibitory T-cell receptor Note: Prior treatment with an anti-PD-1, anti-PD- L1, or anti-PD-L2 agent in the neoadjuvant or adjuvant setting for nonmetastatic resectable NSCLC is allowed as long as therapy was completed at least 12 months before diagnosis of metastatic NSCLC.
  • Received prior systemic anticancer therapy including investigational agents within 4 weeks before randomization.
  • Received radiation therapy to the lung that is >30 Gy within 6 months of start of study intervention.
  • Received prior radiotherapy within 2 weeks of start of study intervention, or radiation-related toxicities, requiring corticosteroids.
  • Received a live or live-attenuated vaccine within 30 days before the first dose of study intervention. Administration of killed vaccines are allowed.
  • Diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy
  • Known additional malignancy that is progressing or has required active treatment within the past 3 years.
  • Known active central nervous system (CNS) metastases and/or carcinomatous meningitis.
  • Known intolerance to sacituzumab tirumotecan or pembrolizumab and/or any of their excipients; for pembrolizumab, severe hypersensitivity (≥Grade 3) is exclusionary.
  • Known hypersensitivity to sacituzumab tirumotecan or other biologic therapy.
  • Active autoimmune disease that has required systemic treatment in the past 2 years.
  • History of (noninfectious) pneumonitis/interstitial lung disease (ILD) that required steroids or has current pneumonitis/ILD.
  • Active infection requiring systemic therapy
  • Concurrent active Hepatitis B and Hepatitis C virus infection.
  • Human immunodeficiency virus (HIV)-infected participants with a history of Kaposi's sarcoma and/or Multicentric Castleman's Disease.
  • History of allogeneic tissue/solid organ transplant.
  • Requires treatment with a strong inhibitor or inducer of Cytochrome P450 3A4 (CYP3A4) at least 14 days before the first dose of study intervention and throughout the study.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Pembrolizumab + Sacituzumab tirumotecan

Participants receive sacituzumab tirumotecan via intravenous (IV) infusion on Days 1, 15 and 29 of each 6-week cycle + 400 mg Pembrolizumab every 6 weeks (q6w) via IV infusion on Day 1 of each 6-week cycle for 18 cycles. Additionally, participants receive diphenhydramine (or equivalent), an H2 antagonist of investigator's choice, acetaminophen (or equivalent), and dexamethasone (or equivalent) per each drug's product label prior to the first 4 infusions of sacituzumab tirumotecan. At subsequent infusions, the H2 antagonist and dexamethasone are optional, at the discretion of the investigator.

IV infusion

Andre navn:
  • MK-3475
  • SCH 900475
  • KEYTRUDA®

IV infusion

Andre navn:
  • SKB264
  • MK-2870

Participants are allowed to take supportive care measures at the discretion of the investigator. Prophylactic supportive care measures may include but are not limited to antiemetic agents, antidiarrheal agents, granulocyte and erythroid growth factors, and blood transfusions

Aktiv komparator: Pembrolizumab

Participants receive 400 mg Pembrolizumab via IV infusion q6w on Day 1 of each 6-week cycle for 18 cycles

IV infusion

Andre navn:
  • MK-3475
  • SCH 900475
  • KEYTRUDA®

Participants are allowed to take supportive care measures at the discretion of the investigator. Prophylactic supportive care measures may include but are not limited to antiemetic agents, antidiarrheal agents, granulocyte and erythroid growth factors, and blood transfusions

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Overall Survival (OS)
Tidsramme: Up to approximately 49 months

OS is defined as the time from randomization to death from any cause.

Up to approximately 49 months

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Progression free survival (PFS)
Tidsramme: Up to approximately 49 months

PFS is defined as the time from randomization to the first documented disease progression per RECIST 1.1 based on BICR or death due to any cause, whichever occurs first

Up to approximately 49 months
Objective Response (OR)
Tidsramme: Up to approximately 49 months

The OR is defined as a confirmed complete response (CR) or partial response (PR) per RECIST 1.1 as assessed by BICR.

Up to approximately 49 months
Duration of Response (DOR)
Tidsramme: Up to approximately 49 months

For participants who demonstrate confirmed CR or PR per RECIST 1.1 as assessed by BICR, duration of response is defined as the time from the first documented evidence of CR or PR until disease progression or death due to any cause, whichever occurs first.

Up to approximately 49 months
Change from Baseline in Global Health Status/Quality of Life (QOL) [European Organisation for Research and Treatment of Cancer (EORTC) Core Quality of Life Questionnaire (QLQ-C30) 29 Items and 30] Score
Tidsramme: Baseline and up to approximately 77 months

Change from baseline in the score of EORTC QLQ-C30 Items 29 and 30 will be presented. The EORTC-QLQ-C30 is a 30-item questionnaire developed to assess the quality of life of cancer patients. Participant responses to Items 29 and 30 ("How would you rate your overall health during the past week?" and "How would you rate your overall quality of life during the past week?") are scored on a 7-point scale (1=Very Poor to 7=Excellent). A higher score indicates a better overall outcome.

Baseline and up to approximately 77 months
Change From Baseline in Dyspnea (EORTC QLQ-C30 Item 8) Score
Tidsramme: Baseline and up to approximately 77 months

Change from baseline in the score of EORTC QLQ-C30 Item 8 will be presented. The EORTC QLQ-C30 is a cancer specific health-related quality-of life (QoL) questionnaire. Participant response to the question "Were you short of breath?" is scored on a 4-point scale (1=Not at All to 4=Very Much). A higher score indicates a worse level of dyspnea.

Baseline and up to approximately 77 months
Change From Baseline in Cough (EORTC QLQ-LC13 Item 31) Score
Tidsramme: Baseline and up to approximately 77 months

Change from baseline in the score of EORTC QLQ-C13 Item 31 will be presented. The EORTC QLQ-C13 is a lung cancer specific health-related quality-of life (QoL) questionnaire. Participant response to the question "Have you coughed?" is scored on a 4-point scale (1=Not at All to 4=Very Much). A higher score indicates more frequent coughing.

Baseline and up to approximately 77 months
Change From Baseline in Chest Pain (EORTC QLQ-LC13 item 40) Score
Tidsramme: Baseline and up to approximately 77 months

The EORTC QLQ-LC13 is a lung cancer-specific supplemental questionnaire used in combination with the EORTC QLQ-C30. Participant responses to the question "Have you had pain in your chest?" are scored on a 4-point scale (1=Not at All to 4=Very Much). Using linear transformation, raw scores are standardized, so that scores range from 0 to 100. The change from baseline in chest pain (EORTC QLQ-LC13 Item 40) score will be presented. A lower score indicates a better outcome.

Baseline and up to approximately 77 months
Time to Deterioration (TTD) Based on Change From Baseline in Global Health Status (GHS)/ QOL Score (EORTC QLQ-C30 Item 29 and 30)
Tidsramme: Up to approximately 77 months

The TTD in GHS/QOL score (EORTC QLQ-C30 Items 29 and 30) will be presented. Participant responses to Items 29 and 30 ("How would you rate your overall health during the past week?" and "How would you rate your overall quality of life during the past week?") are scored on a 7-point scale (1=Very Poor to 7=Excellent). A higher score indicates a better overall outcome. TTD as assessed based on a negative change (decrease in score) from Baseline in GHS/QOL score. A longer TTD indicates a better outcome.

Up to approximately 77 months
Time to Deterioration (TTD) Based on Change From Baseline in Dyspnea Score (EORTC QLQ-C30 Item 8)
Tidsramme: Up to approximately 77 months

The TTD in Dyspnea score (EORTC QLQ-C30 Item 8) will be presented. Participant response to the question "Were you short of breath?" is scored on a 4-point scale (1=Not at All to 4=Very Much). A higher score indicates a worse level of dyspnea. TTD is assessed based on the time to a negative change (increase in score) from baseline. A longer TTD indicates a better outcome.

Up to approximately 77 months
Time to Deterioration (TTD) Based on Change From Baseline in Cough Score (EORTC QLQ-LC13 Item 31).
Tidsramme: Up to approximately 77 months

The TTD in Cough score (EORTC QLQ-LC13 Item 31) will be presented. Participant response to the question "Have you coughed?" is scored on a 4-point scale (1=Not at All to 4=Very Much). A higher score indicates more frequent coughing. TTD is assessed based on the time to a negative change (increase in score) from baseline. A longer TTD indicates a better outcome.

Up to approximately 77 months
Time to Deterioration (TTD) Based on Change From Baseline in Chest Pain Score (EORTC QLQ-LC13 Item 40)
Tidsramme: Up to approximately 77 months

The TTD in Chest Pain score (EORTC QLQ-LC13 Item 40) will be presented. Participant response to the question "Have you had pain in your chest?" is scored on a 4-point scale (1=Not at All to 4=Very Much). A higher score indicates a worse level of chest pain. TTD is assessed based on the time to a negative change (increase in score) from baseline. A longer TTD indicates a better outcome.

Up to approximately 77 months
Percentage of Participants That Experience at Least 1 Adverse Event
Tidsramme: Up to approximately 77 months

An AE is any untoward medical occurrence in a participant, temporally associated with the use of study treatment, whether or not considered related to the study treatment. The percentage of participants who experience an AE will be presented.

Up to approximately 77 months
Percentage of Participants Who Discontinue Study Treatment Due to an AE
Tidsramme: Up to approximately 77 months

The percentage of participants who discontinue study treatment due to an AE will be presented.

Up to approximately 77 months

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Studieleder: Medical Director, Merck Sharp & Dohme LLC

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

15. desember 2023

Primær fullføring (Antatt)

25. januar 2028

Studiet fullført (Antatt)

27. mai 2030

Datoer for studieregistrering

Først innsendt

3. desember 2023

Først innsendt som oppfylte QC-kriteriene

6. desember 2023

Først lagt ut (Faktiske)

14. desember 2023

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

3. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

30. oktober 2026

Sist bekreftet

1. oktober 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • 2870-007
  • MK-2870-007 (Annen identifikator: MSD)
  • 2023-503376-24-00 (Annen identifikator: EU CT)
  • jRCT2051240089 (Registeridentifikator: Japan Registry of Clinical Trials (jRCT))
  • U1111-1287-1395 (Registeridentifikator: UTN)
  • 2023 (U.S. NIH-stipend/kontrakt)

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

JA

IPD-planbeskrivelse

https://trialstransparency.msdclinicaltrials.com/pdf/ProcedureAccessClinicalTrialData.pdf

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Ja

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere